InvestorsObserver
×
News Home

Is Aurinia Pharmaceuticals Inc (AUPH) a Winner in the Healthcare Sector?

Friday, November 24, 2023 12:30 PM | InvestorsObserver Analysts

Mentioned in this article

Is Aurinia Pharmaceuticals Inc (AUPH) a Winner in the Healthcare Sector?

Aurinia Pharmaceuticals Inc (AUPH) is near the top in its sector according to InvestorsObserver. AUPH gets an overall rating of 88. That means it scores higher than 88% of stocks. Aurinia Pharmaceuticals Inc gets a 89 rank in the Healthcare sector. Healthcare is number 5 out of 11 sectors.

Overall Score - 88
AUPH has an Overall Score of 88. Find out what this means to you and get the rest of the rankings on AUPH!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Aurinia Pharmaceuticals Inc Stock Today?

Aurinia Pharmaceuticals Inc (AUPH) stock has gained 2.16% while the S&P 500 is lower by -0.02% as of 12:14 PM on Friday, Nov 24. AUPH is up $0.19 from the previous closing price of $9.04 on volume of 1,013,626 shares. Over the past year the S&P 500 has gained 13.15% while AUPH is up 89.34%. AUPH lost -$0.54 per share the over the last 12 months. Click Here to get the full Stock Report for Aurinia Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App